alexis ohanian glp 1 Serena Williams' Super Bowl ad promoting a GLP-1 weight loss drug sparks backlash Chad Sanders | Serena Williams

The number of therapeutic options is limited and are often associated with adverse side effects

Menopause weight, constant hunger or low energy

and in the UK, over 400,000 patients are paying for AOMs out of pocket

This unique regulatory situation is contributing to a more competitive market somewhat earlier than in the U.S

This may help combat post-meal sluggishness and support steady energy levels throughout the day.* ENCOURAGE NATURAL FAT BURNING & WEIGHT MANAGEMENT* As appetite balance improves, the body may more effectively tap into stored fat for energy

The recent approval of OZEMPIC reinforces the growing trend of GLP-1 drugs being used for conditions beyond diabetes and weight loss.